Majeed Aleena, Naz Nageen, Namal Fnu, Tahir Sohaira, Karmani Vikash Kumar
Internal Medicine, Fatima Jinnah Medical University, Lahore, PAK.
Internal Medicine, Social Security Hospital, Faisalabad, PAK.
Cureus. 2024 Sep 16;16(9):e69510. doi: 10.7759/cureus.69510. eCollection 2024 Sep.
Chronic traumatic encephalopathy (CTE) is a progressive and fatal neurological disorder linked to repeated traumatic brain injuries (TBIs), including concussions and blows to the head. This condition is characterized by the accumulation of abnormally structured hyperphosphorylated tau proteins (p-tau), forming neurofibrillary tangles, astrocytic tangles, and neurites in the brain. CTE is often diagnosed post-mortem, making it challenging to diagnose and predict its progression in living individuals. Despite recent advancements, no definitive pathological, radiological, or neurobiological marker consistently shows promise in diagnosing and predicting the disease. This review aims to summarize the available techniques and advancements in imaging-based, genetic, neuropsychological, and fluid biomarkers for CTE, evaluating their specificity and sensitivity. It will also highlight the limitations of each marker in diagnosing CTE and provide future research directions to enhance the accuracy of CTE diagnosis in living individuals.
慢性创伤性脑病(CTE)是一种进行性致命性神经疾病,与反复的创伤性脑损伤(TBI)有关,包括脑震荡和头部撞击。这种疾病的特征是大脑中异常结构的高磷酸化tau蛋白(p-tau)积累,形成神经原纤维缠结、星形细胞缠结和神经突。CTE通常在死后诊断,这使得在活体中诊断和预测其进展具有挑战性。尽管最近有进展,但没有明确的病理、放射或神经生物学标志物在诊断和预测该疾病方面始终显示出前景。本综述旨在总结CTE在基于成像、基因、神经心理学和体液生物标志物方面的现有技术和进展,评估其特异性和敏感性。它还将强调每种标志物在诊断CTE方面的局限性,并提供未来的研究方向,以提高在活体中CTE诊断的准确性。